Cancer Research UK and Greater Manchester Health and Social Care Partnership commissioned the Office of Health Economics, RAND Europe and Kings College London, February 2019
- This report explores the feasibility of introducing outcome-based payment (OBP) for cancer medicines into the NHS in England. This model links the price the NHS pays for a medicine to the outcomes it achieves in practice for NHS patients.
